Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | LCK | P06239 | 2/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.55 |
| ▸ | USP2 | O75604 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | FYN | P06241 | 1/20 | 0.55 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.55 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.55 |
| ▸ | HTR2A | P28223 | 1/20 | 0.55 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.55 |
| ▸ | RECQL | P46063 | 1/20 | 0.55 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.55 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.55 |
| ▸ | FOLH1 | Q04609 | 3/20 | 0.53 |
| ▸ | ACE | P12821 | 3/20 | 0.53 |
| ▸ | MME | P08473 | 1/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2339748 | 1.00 | CA1 (0.58) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL10099813 | 0.92 | CA1 (0.56) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL11850661 | 0.88 | CA2 (0.61) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL11277926 | 0.86 | CA2 (0.55) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL18619736 | 0.86 | MME (0.56) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL10824355 | 0.85 | NAALAD2 (0.59) | CA1CA2FOLH1ACEMME | |
| SCHEMBL4629789 | 0.85 | NAALAD2 (0.59) | CA1CA2FOLH1ACEMME | |
| SCHEMBL7293429 | 0.85 | SLC7A5 (0.62) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL27753212 | 0.85 | SLC7A5 (0.62) | CA1CA2LCKKDM4EUSP2 | |
| SCHEMBL11576781 | 0.85 | SLC7A5 (0.62) | CA1CA2LCKKDM4EUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170112773-A1 | PLASMA MEMBRANE VESICLES COMPRISING FUNCTIONAL TRANSMEMBRANE PROTEINS | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM | 2017-04-27 | — | — | US | disclosed |
| EP-1829526-B1 | LIPOSOME AND METHOD OF INJECTING SUBSTANCE INTO CELL BY USING THE SAME | NAT UNIV CORP TOKYO MED & DENT (JP) | 2016-01-20 | — | — | EP | disclosed |
| US-9023384-B2 | Liposome and method for injecting substance to cell using this liposome | TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) | 2015-05-05 | — | — | US | disclosed |
| US-8304452-B2 | Radical scavenger and active oxygen eliminating agent | INBIOTEX INC. (JP) | 2012-11-06 | — | — | US | disclosed |
| US-20110212883-A1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | INBIOTEX INC. (JP) | 2011-09-01 | — | — | US | disclosed |
| EP-1897549-B1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | INBIOTEX INC (JP) | 2011-08-24 | — | — | EP | disclosed |
| US-20100137635-A1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | INBIOTEX INC. (JP) | 2010-06-03 | — | — | US | disclosed |
| US-20080279918-A1 | Composition charged with liposome; injecting into target cell; in vitro protein synthesis in gap between liposomes; drug delivery | NATIONAL UNIVERSITY CORPORATION TOKYO MEDICAL AND DENTAL UNIVERSITY (JP) | 2008-11-13 | — | — | US | disclosed |
| EP-1897549-A1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | InBiotex inc. (JP) | 2008-03-12 | — | — | EP | disclosed |
| EP-1829526-A1 | LIPOSOME AND METHOD OF INJECTING SUBSTANCE INTO CELL BY USING THE SAME | National Universiy Corporation Tokyo Medical and Dental University (JP) | 2007-09-05 | — | — | EP | disclosed |
| WO-2007013147-A1 | ANGIOGENESIS INHIBITOR AND VASCULAR REGRESSIVE AGENT | INBIOTEX INC. (JP) | 2007-02-01 | — | — | WO | disclosed |
| JP-2005213159-A | NEOVASCULARIZATION INHIBITOR AND VASCULAR RETRACTION AGENT | INBIOTEX:KK | 2005-08-11 | — | — | JP | disclosed |
| JP-2001213799-A | ANTINEOPLASTIC | INST OF PHYSICAL & CHEMICAL RES | 2001-08-07 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137635-A1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | GLO1, GPX1, GPX4 | CA1 2218/4885CA2 1233/4885LCK 4110/4885 |
| US-20110212883-A1 | RADICAL SCAVENGER AND ACTIVE OXYGEN ELIMINATING AGENT | GLO1, GPX1, GPX4 | CA1 2473/4885CA2 1280/4885LCK 3859/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.